These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 27705920)

  • 1. Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma.
    Li Z; Chen Y; Hu S; Zhang J; Wu J; Ren W; Shao N; Ying X
    Oncotarget; 2016 Dec; 7(50):82671-82685. PubMed ID: 27705920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-coding RNA and gene expression analyses of papillary renal neoplasm with reverse polarity (PRNRP) reveal distinct pathological mechanisms from other renal neoplasms.
    Nemours S; Armesto M; Arestín M; Manini C; Giustetto D; Sperga M; Pivovarcikova K; Pérez-Montiel D; Hes O; Michal M; López JI; Lawrie CH
    Pathology; 2024 Jun; 56(4):493-503. PubMed ID: 38413252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer.
    Liu YR; Jiang YZ; Xu XE; Yu KD; Jin X; Hu X; Zuo WJ; Hao S; Wu J; Liu GY; Di GH; Li DQ; He XH; Hu WG; Shao ZM
    Breast Cancer Res; 2016 Mar; 18(1):33. PubMed ID: 26975198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive bioinformatics analysis of KIF20A as a prognosis biomarker for clear cell renal cell carcinoma.
    Xie C; Yiu W; Mo Y
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):116-124. PubMed ID: 38650144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel biomarkers to distinguish clear cell and non-clear cell renal cell carcinoma using bioinformatics and machine learning.
    Panwoon C; Seubwai W; Thanee M; Sangkhamanon S
    PLoS One; 2024; 19(6):e0305252. PubMed ID: 38857246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stemness related lncRNAs signature for the prognosis and tumor immune microenvironment of ccRCC patients.
    Zhang M; Zhang J; Liang X; Zhang M
    BMC Med Genomics; 2024 May; 17(1):150. PubMed ID: 38822402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Risk Signature with Autophagy-Related Long Noncoding RNAs for Predicting the Prognosis of Clear Cell Renal Cell Carcinoma: Based on the TCGA Database and Bioinformatics.
    Xuan Y; Chen W; Liu K; Gao Y; Zuo S; Wang B; Ma X; Zhang X
    Dis Markers; 2021; 2021():8849977. PubMed ID: 34040677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering glutamine metabolism patterns for malignancy and tumor microenvironment in clear cell renal cell carcinoma.
    Wu G; Li T; Chen Y; Ye S; Zhou S; Tian X; Anwaier A; Zhu S; Xu W; Hao X; Ye D; Zhang H
    Clin Exp Med; 2024 Jul; 24(1):152. PubMed ID: 38970690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular subtypes of clear cell renal carcinoma based on PCD-related long non-coding RNAs expression: insights into the underlying mechanisms and therapeutic strategies.
    Wang H; Liu Y; Tang A; Zhang X
    Eur J Med Res; 2024 May; 29(1):292. PubMed ID: 38773560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key genes and signalling pathways in clear cell renal cell carcinoma: An integrated bioinformatics approach.
    S V; Balasubramanian S; Perumal E; Santhakumar K
    Cancer Biomark; 2024; 40(1):111-123. PubMed ID: 38427469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine Learning Gene Signature to Metastatic ccRCC Based on ceRNA Network.
    Farias E; Terrematte P; Stransky B
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The integrate profiling of single-cell and spatial transcriptome RNA-seq reveals tumor heterogeneity, therapeutic targets, and prognostic subtypes in ccRCC.
    Zhang Y; Huang X; Yu M; Zhang M; Zhao L; Yan Y; Zhang L; Wang X
    Cancer Gene Ther; 2024 Jun; 31(6):917-932. PubMed ID: 38480978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression analysis identifies a prognostically significant extracellular matrix-enriched gene signature in hyaluronan-positive clear cell renal cell carcinoma.
    Jokelainen O; Rintala TJ; Fortino V; Pasonen-Seppänen S; Sironen R; Nykopp TK
    Sci Rep; 2024 May; 14(1):10626. PubMed ID: 38724670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of miRNA signatures for kidney renal clear cell carcinoma using the tensor-decomposition method.
    Ng KL; Taguchi YH
    Sci Rep; 2020 Sep; 10(1):15149. PubMed ID: 32938959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive proteogenomic characterization of rare kidney tumors.
    Li GX; Chen L; Hsiao Y; Mannan R; Zhang Y; Luo J; Petralia F; Cho H; Hosseini N; Leprevost FDV; Calinawan A; Li Y; Anand S; Dagar A; Geffen Y; Kumar-Sinha C; Chugh S; Le A; Ponce S; Guo S; Zhang C; Schnaubelt M; Al Deen NN; Chen F; Caravan W; Houston A; Hopkins A; Newton CJ; Wang X; Polasky DA; Haynes S; Yu F; Jing X; Chen S; Robles AI; Mesri M; Thiagarajan M; An E; Getz GA; Linehan WM; Hostetter G; Jewell SD; Chan DW; Wang P; Omenn GS; Mehra R; Ricketts CJ; Ding L; Chinnaiyan AM; Cieslik MP; Dhanasekaran SM; Zhang H; Nesvizhskii AI;
    Cell Rep Med; 2024 May; 5(5):101547. PubMed ID: 38703764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification.
    Inamura K
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29053609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancer.
    Christinat Y; Krek W
    Oncotarget; 2015 Apr; 6(12):10521-31. PubMed ID: 25826081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with ClearCode34-identified molecular subtypes of clear cell renal cell carcinoma represent unique populations with distinct comorbidities.
    Haake SM; Brooks SA; Welsh E; Fulp WJ; Chen DT; Dhillon J; Haura E; Sexton W; Spiess PE; Pow-Sang J; Rathmell WK; Fishman M
    Urol Oncol; 2016 Mar; 34(3):122.e1-7. PubMed ID: 26546482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma.
    Seles M; Hutterer GC; Kiesslich T; Pummer K; Berindan-Neagoe I; Perakis S; Schwarzenbacher D; Stotz M; Gerger A; Pichler M
    Int J Mol Sci; 2016 Apr; 17(4):573. PubMed ID: 27092491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitophagy and clear cell renal cell carcinoma: insights from single-cell and spatial transcriptomics analysis.
    Jiang L; Ren X; Yang J; Chen H; Zhang S; Zhou X; Huang J; Jiang C; Gu Y; Tang J; Yang G; Chi H; Qin J
    Front Immunol; 2024; 15():1400431. PubMed ID: 38994370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.